Jennifer L. Brown

Pfizer
Senior Director, Global Regulatory Affairs, CMC
Jennifer L. Brown is a Senior Director in the CMC group within Global Regulatory Sciences at Pfizer Inc in Groton, Connecticut. She and her team are responsible for CMC strategy for a global portfolio of investigational and commercial small molecule products. At Pfizer, Brown is currently a co-chair of the Excipient Council and is a member of the China Regulatory Network and Early Development Portfolio Management Group, and externally she chairs the ISPE Asia-Pacific Regional Focus Group and is secretary of the AAPS Regulatory Science Community. Brown received a B.S. in Chemistry from Muhlenberg College in Allentown, Pennsylvania, and an M.S. in Regulatory Affairs/Quality Assurance from Temple University. She started at Pfizer in Analytical R&D and has worked in Regulatory CMC for the past 25 years or so. Prior to joining Pfizer, she was a Peace Corps volunteer in Gabon, Central Africa, teaching middle school science, and Jen also served as a Pfizer Global Health Fellow, working at the Kakuma Refugee Camp in northern Kenya for several months in 2005. She is the current chair of the ISPE RQHC Asia-Pacific Regional Focus Group.

Related Articles

Asia Pacific Region Map - Image by Freepik
iSpeak Blog
ISPE Regulatory Volunteers Highlight Regulatory Challenges and Reform in Asia-Pacific

ISPE’s Regulatory Quality Harmonization Committee (RQHC) is structured with four Regional Focus Groups (RFGs): Asia-Pacific, Europe/Middle East/Africa, Latin America, and North America. The RFGs support ISPE in its understanding and response to regulatory issues and concerns for the specific region. The RQHC Asia-Pacific RFG includes pharmaceutical professionals located in or having specific...

A Proposal for a Comprehensive Quality Overall Summary
Features
A Proposal for a Comprehensive Quality Overall Summary

When working with the common technical dossier (CTD), the structure of Module 2 “follows the scope and outline of the Body of Data in Module 3,”International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. “Concept Paper: M4Q(R2) Common Technical Document on Quality Guideline.” Published 15 November 2021.

Is a Globally Harmonized Quality Overall Summary Possible?
Features
Is a Globally Harmonized Quality Overall Summary Possible?

The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guideline on Registration of Pharmaceuticals for Human Use (M4)International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. “The Common Technical Document for the Registration of Pharmaceuticals for Human Use: Quality–M4Q (R1)...